Y Intercept Hong Kong Ltd Grows Stake in Tenet Healthcare Corporation $THC

Y Intercept Hong Kong Ltd boosted its stake in Tenet Healthcare Corporation (NYSE:THC) by 174.5% during the first quarter, HoldingsChannel reports. The institutional investor owned 63,397 shares of the company’s stock after buying an additional 40,299 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Tenet Healthcare were worth $11,964,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of THC. Elevation Point Wealth Partners LLC acquired a new position in shares of Tenet Healthcare during the first quarter valued at approximately $497,000. Root Financial Partners LLC increased its position in shares of Tenet Healthcare by 146.4% during the first quarter. Root Financial Partners LLC now owns 658 shares of the company’s stock worth $124,000 after purchasing an additional 391 shares in the last quarter. Fulton Bank N.A. raised its stake in Tenet Healthcare by 7.8% in the 1st quarter. Fulton Bank N.A. now owns 1,945 shares of the company’s stock valued at $367,000 after purchasing an additional 140 shares during the last quarter. Brown Miller Wealth Management LLC lifted its holdings in Tenet Healthcare by 8.1% in the 1st quarter. Brown Miller Wealth Management LLC now owns 1,932 shares of the company’s stock valued at $365,000 after purchasing an additional 145 shares in the last quarter. Finally, Janney Montgomery Scott LLC grew its holdings in shares of Tenet Healthcare by 10.6% during the first quarter. Janney Montgomery Scott LLC now owns 23,662 shares of the company’s stock worth $4,465,000 after buying an additional 2,267 shares in the last quarter. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Tenet Healthcare Stock Performance

Tenet Healthcare stock opened at $204.28 on Friday. The firm has a 50 day simple moving average of $181.22 and a 200-day simple moving average of $197.26. The stock has a market cap of $17.60 billion, a price-to-earnings ratio of 10.62, a price-to-earnings-growth ratio of 1.57 and a beta of 1.27. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. Tenet Healthcare Corporation has a 1-year low of $146.60 and a 1-year high of $247.21.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, beating the consensus estimate of $4.21 by $0.61. The firm had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $4.36 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, analysts expect that Tenet Healthcare Corporation will post 17.61 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on THC. Wells Fargo & Company lowered their price target on shares of Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Weiss Ratings lowered shares of Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 2nd. Royal Bank Of Canada dropped their price target on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a research report on Friday, May 1st. Robert W. Baird reduced their price objective on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 5th. Finally, Mizuho upped their target price on Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a report on Thursday, March 12th. Eighteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, Tenet Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $244.32.

Insider Buying and Selling at Tenet Healthcare

In other news, Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the transaction, the director owned 16,804 shares of the company’s stock, valued at $2,932,634.08. This represents a 25.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Nadja West sold 3,000 shares of the firm’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the sale, the director directly owned 24,805 shares of the company’s stock, valued at $4,399,166.75. The trade was a 10.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.97% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.